Significant Publications on Infectious Diseases Pharmacotherapy in 2023
Journal of Pharmacy Practice · 2025
DOI: 10.1177/08971900251318816 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Pharmacy Practice, 2025. Verfasst von Alex V Stabler und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Hauptthemen laut MEDLINE: Communicable Diseases, Anti-Infective Agents. Die Arbeit nennt 81 Literaturangaben.
Abstract (Originalsprache)
Purpose
To provide a summarization of the most significant infectious diseases (ID) pharmacotherapy articles published in peer-reviewed literature in 2023. Summary: Members of the Houston Infectious Diseases Network (HIDN) nominated notable articles providing significant contributions to ID pharmacotherapy in 2023. Article nominations included those pertaining to general ID and human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) pharmacotherapy. Out of the 31 articles nominated by HIDN members, 22 pertained to general ID pharmacotherapy, and 9 pertained to HIV/AIDS pharmacotherapy. To aid selection of the most notable articles of 2023, a survey was created and distributed to members of the Society of Infectious Diseases Pharmacists (SIDP). Of the 153 SIDP members who participated in the survey, there were 118 recorded votes for the top 10 general ID pharmacotherapy articles and 55 votes were recorded for the top HIV/AIDS article. The most notable publications are summarized.
Conclusion
Advances in antimicrobial stewardship and infectious disease states continue to occur. Sustained growth in the publication of ID-related articles over the past year contributed to this review’s aim to aid clinicians in remaining current on potentially practice-changing ID pharmacotherapy publications from 2023. This review provides a summary of recently published ID literature, including emphasis on antimicrobial stewardship, appropriate treatment durations, new antimicrobials, and drug-resistant organisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
- Department of Pharmacy, Baylor St. Luke's Medical Center, Houston, TX, USA.
- Department of Pharmacy, The University of Texas Medical Branch, Galveston, TX, USA.
- Department of Pharmacy, Houston Methodist Hospital, Houston, TX, USA.
- Department of Pharmacy, Memorial Hermann Memorial City Medical Center, Houston, TX, USA.
- Department of Pharmacy, Memorial Hermann Southwest, Houston, TX, USA.
ORCID-Profile: Alex V Stabler, Ricky Huynh-Phan, Khyati Amin, Kevin Lin, Stefanie Stramel, Jamie L Thomas
Zitieren
APA
Stabler, A. V., Huynh-Phan, R., Amin, K., Lin, K., Patel, S., Zaidan, N., Stramel, S., & Thomas, J. L. (2025). Significant Publications on Infectious Diseases Pharmacotherapy in 2023. Journal of Pharmacy Practice. https://doi.org/10.1177/08971900251318816
Vancouver
Stabler AV, Huynh-Phan R, Amin K, Lin K, Patel S, Zaidan N, et al. Significant Publications on Infectious Diseases Pharmacotherapy in 2023. Journal of Pharmacy Practice. 2025. doi:10.1177/08971900251318816
BibTeX
@article{Stabler2025,
author = {Stabler, Alex V and Huynh-Phan, Ricky and Amin, Khyati and Lin, Kevin and Patel, Shivani and Zaidan, Noor and Stramel, Stefanie and Thomas, Jamie L},
title = {Significant Publications on Infectious Diseases Pharmacotherapy in 2023},
journal = {Journal of Pharmacy Practice},
year = {2025},
doi = {10.1177/08971900251318816}
}
EUVIMED